Artelo Biosciences, Inc.

In the quarter to June 2026, EPS grew 94.7% and free cash flow fell 879.2%, each against the same quarter a year earlier.

2.70 0.04 −1.46%

Follow ARTL

Alert me

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(705.71%)	(367.70%)	(1,625.11%)	(436.14%)	+8 more TTM periods Free account
ROA Full definition →	(234.30%)	(167.97%)	(343.49%)	(219.08%)
ROIC Full definition →	(865.85%)	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(434.53%)	(293.16%)	384.56%	411.84%
Average Days of Receivables Full definition →	—	—	—	—
Free Cash Flow per Share Full definition →	(41.93)	(98.83)	(223.62)	(280.96)
Free Cash Flow Full definition →	(12.63)	(8.11)	(8.52)	(8.18)
Other line items
Cash ROIC Full definition →	(137.39%)	(47.88%)	1,267.86%	(752.16%)
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Interest Coverage Full definition →	(33.04)	(29.21)	(40.44)	(65.77)
Operating CF/Net income Full definition →	1.00	0.60	0.66	0.65
Depreciation/Fixed assets Full definition →	0.00	0.00	0.00	0.00
Capex/Depreciation Full definition →	0.00	0.00	0.00	0.00
Revenue per Share Full definition →	0.00	0.00	0.00	0.00
Operating CF per Share Full definition →	(41.93)	(98.83)	(223.62)	(280.96)
Capex per Share Full definition →	0.00	0.00	0.00	0.00

Columns are period end dates · fundamentals updated 28 Sep 2026